ReviewCancers2022

EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies.

Ivana Samaržija et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.